Literature DB >> 30310462

Guest Editorial: Reducing Risk in Familial Hypercholesterolaemia and Severe Dyslipidaemia: Novel Drugs Targeting PCSK9.

Antonio J Vallejo-Vaz1.   

Abstract

Entities:  

Year:  2018        PMID： 30310462      PMCID： PMC6159434          DOI： 10.15420/ecr.2018.13.1.GE3

Source DB:  PubMed          Journal:  Eur Cardiol        ISSN： 1758-3756


× No keyword cloud information.
  11 in total

1.  Familial hypercholesterolaemia: A global call to arms.

Authors:  Antonio J Vallejo-Vaz; Sreenivasa Rao Kondapally Seshasai; Della Cole; G Kees Hovingh; John J P Kastelein; Pedro Mata; Frederick J Raal; Raul D Santos; Handrean Soran; Gerald F Watts; Marianne Abifadel; Carlos A Aguilar-Salinas; Asif Akram; Fahad Alnouri; Rodrigo Alonso; Khalid Al-Rasadi; Maciej Banach; Martin P Bogsrud; Mafalda Bourbon; Eric Bruckert; Josip Car; Pablo Corral; Olivier Descamps; Hans Dieplinger; Ronen Durst; Tomas Freiberger; Isabel M Gaspar; Jaques Genest; Mariko Harada-Shiba; Lixin Jiang; Meral Kayikcioglu; Carolyn S P Lam; Gustavs Latkovskis; Ulrich Laufs; Evangelos Liberopoulos; Lennart Nilsson; Børge G Nordestgaard; John M O'Donoghue; Amirhossein Sahebkar; Heribert Schunkert; Abdulla Shehab; Mario Stoll; Ta-Chen Su; Andrey Susekov; Elisabeth Widén; Alberico L Catapano; Kausik K Ray
Journal:  Atherosclerosis       Date:  2015-09-18       Impact factor: 5.162

2.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Alberico L Catapano; Ian Graham; Guy De Backer; Olov Wiklund; M John Chapman; Heinz Drexel; Arno W Hoes; Catriona S Jennings; Ulf Landmesser; Terje R Pedersen; Željko Reiner; Gabriele Riccardi; Marja-Riita Taskinen; Lale Tokgozoglu; W M Monique Verschuren; Charalambos Vlachopoulos; David A Wood; Jose Luis Zamorano
Journal:  Atherosclerosis       Date:  2016-09-01       Impact factor: 5.162

3.  2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia.

Authors:  Ulf Landmesser; M John Chapman; Jane K Stock; Pierre Amarenco; Jill J F Belch; Jan Borén; Michel Farnier; Brian A Ference; Stephan Gielen; Ian Graham; Diederick E Grobbee; G Kees Hovingh; Thomas F Lüscher; Massimo F Piepoli; Kausik K Ray; Erik S Stroes; Olov Wiklund; Stephan Windecker; Jose Luis Zamorano; Fausto Pinto; Lale Tokgözoglu; Jeroen J Bax; Alberico L Catapano
Journal:  Eur Heart J       Date:  2018-04-07       Impact factor: 29.983

4.  Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.

Authors:  Leopoldo Perez de Isla; Rodrigo Alonso; Gerald F Watts; Nelva Mata; Adriana Saltijeral Cerezo; Ovidio Muñiz; Francisco Fuentes; José Luís Diaz-Diaz; Raimundo de Andrés; Daniel Zambón; Patricia Rubio-Marin; Miguel A Barba-Romero; Pedro Saenz; Juan F Sanchez Muñoz-Torrero; Ceferino Martinez-Faedo; José P Miramontes-Gonzalez; Lina Badimón; Pedro Mata
Journal:  J Am Coll Cardiol       Date:  2016-03-22       Impact factor: 24.094

5.  Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

Authors:  Marc S Sabatine; Robert P Giugliano; Anthony C Keech; Narimon Honarpour; Stephen D Wiviott; Sabina A Murphy; Julia F Kuder; Huei Wang; Thomas Liu; Scott M Wasserman; Peter S Sever; Terje R Pedersen
Journal:  N Engl J Med       Date:  2017-03-17       Impact factor: 91.245

Review 6.  The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.

Authors:  Jean-Charles Fruchart; Frank M Sacks; Michel P Hermans; Gerd Assmann; W Virgil Brown; Richard Ceska; M John Chapman; Paul M Dodson; Paola Fioretto; Henry N Ginsberg; Takashi Kadowaki; Jean-Marc Lablanche; Nikolaus Marx; Jorge Plutzky; Zeljko Reiner; Robert S Rosenson; Bart Staels; Jane K Stock; Rody Sy; Christoph Wanner; Alberto Zambon; Paul Zimmet
Journal:  Diab Vasc Dis Res       Date:  2008-11       Impact factor: 3.291

7.  Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

Authors:  John C LaRosa; Scott M Grundy; David D Waters; Charles Shear; Philip Barter; Jean-Charles Fruchart; Antonio M Gotto; Heiner Greten; John J P Kastelein; James Shepherd; Nanette K Wenger
Journal:  N Engl J Med       Date:  2005-03-08       Impact factor: 91.245

8.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.

Authors:  Børge G Nordestgaard; M John Chapman; Steve E Humphries; Henry N Ginsberg; Luis Masana; Olivier S Descamps; Olov Wiklund; Robert A Hegele; Frederick J Raal; Joep C Defesche; Albert Wiegman; Raul D Santos; Gerald F Watts; Klaus G Parhofer; G Kees Hovingh; Petri T Kovanen; Catherine Boileau; Maurizio Averna; Jan Borén; Eric Bruckert; Alberico L Catapano; Jan Albert Kuivenhoven; Päivi Pajukanta; Kausik Ray; Anton F H Stalenhoef; Erik Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen
Journal:  Eur Heart J       Date:  2013-08-15       Impact factor: 29.983

Review 9.  Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.

Authors:  Brian A Ference; Henry N Ginsberg; Ian Graham; Kausik K Ray; Chris J Packard; Eric Bruckert; Robert A Hegele; Ronald M Krauss; Frederick J Raal; Heribert Schunkert; Gerald F Watts; Jan Borén; Sergio Fazio; Jay D Horton; Luis Masana; Stephen J Nicholls; Børge G Nordestgaard; Bart van de Sluis; Marja-Riitta Taskinen; Lale Tokgözoglu; Ulf Landmesser; Ulrich Laufs; Olov Wiklund; Jane K Stock; M John Chapman; Alberico L Catapano
Journal:  Eur Heart J       Date:  2017-08-21       Impact factor: 29.983

10.  Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.

Authors:  Marina Cuchel; Eric Bruckert; Henry N Ginsberg; Frederick J Raal; Raul D Santos; Robert A Hegele; Jan Albert Kuivenhoven; Børge G Nordestgaard; Olivier S Descamps; Elisabeth Steinhagen-Thiessen; Anne Tybjærg-Hansen; Gerald F Watts; Maurizio Averna; Catherine Boileau; Jan Borén; Alberico L Catapano; Joep C Defesche; G Kees Hovingh; Steve E Humphries; Petri T Kovanen; Luis Masana; Päivi Pajukanta; Klaus G Parhofer; Kausik K Ray; Anton F H Stalenhoef; Erik Stroes; Marja-Riitta Taskinen; Albert Wiegman; Olov Wiklund; M John Chapman
Journal:  Eur Heart J       Date:  2014-07-22       Impact factor: 35.855
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.